
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
Bojan F. Hörnich, Anna K. Großkopf, Sarah Schlagowski, et al.
Journal of Virology (2021) Vol. 95, Iss. 9
Open Access | Times Cited: 101
Bojan F. Hörnich, Anna K. Großkopf, Sarah Schlagowski, et al.
Journal of Virology (2021) Vol. 95, Iss. 9
Open Access | Times Cited: 101
Showing 1-25 of 101 citing articles:
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2384-2393.e12
Open Access | Times Cited: 995
Markus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2384-2393.e12
Open Access | Times Cited: 995
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
Dennis Lapuente, Jana Fuchs, Jonas Willar, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 188
Dennis Lapuente, Jana Fuchs, Jonas Willar, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 188
Proteolytic activation of SARS‐CoV‐2 spike protein
Makoto Takeda
Microbiology and Immunology (2021) Vol. 66, Iss. 1, pp. 15-23
Open Access | Times Cited: 173
Makoto Takeda
Microbiology and Immunology (2021) Vol. 66, Iss. 1, pp. 15-23
Open Access | Times Cited: 173
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 172
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 172
Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation
Bryan J. Fraser, Serap Beldar, Almagul Seitova, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 9, pp. 963-971
Open Access | Times Cited: 164
Bryan J. Fraser, Serap Beldar, Almagul Seitova, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 9, pp. 963-971
Open Access | Times Cited: 164
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 135
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 135
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
Georg Jocher, Vincent Grass, Sarah K. Tschirner, et al.
EMBO Reports (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 103
Georg Jocher, Vincent Grass, Sarah K. Tschirner, et al.
EMBO Reports (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 103
Long Covid: where we stand and challenges ahead
Alberto Mantovani, Maria Concetta Morrone, Carlo Patrono, et al.
Cell Death and Differentiation (2022)
Open Access | Times Cited: 101
Alberto Mantovani, Maria Concetta Morrone, Carlo Patrono, et al.
Cell Death and Differentiation (2022)
Open Access | Times Cited: 101
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Maren Schubert, Federico Bertoglio, Stephan Steinke, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
Jonathan H. Shrimp, Stephen C. Kales, Philip E.J. Sanderson, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 5, pp. 997-1007
Open Access | Times Cited: 126
Jonathan H. Shrimp, Stephen C. Kales, Philip E.J. Sanderson, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 5, pp. 997-1007
Open Access | Times Cited: 126
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
Mai Kishimoto, Kentaro Uemura, Takao Sanaki, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 75
Mai Kishimoto, Kentaro Uemura, Takao Sanaki, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 75
SARS-CoV-2 Antiviral Therapy
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 4
Open Access | Times Cited: 57
Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Xinyu Li, Huijun Yuan, Xiaozhen Li, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 28
Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 28
Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications
Siva Sundara Kumar Durairajan, Abhay Singh, Udhaya Bharathy Saravanan, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1231-1231
Open Access | Times Cited: 24
Siva Sundara Kumar Durairajan, Abhay Singh, Udhaya Bharathy Saravanan, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1231-1231
Open Access | Times Cited: 24
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 17
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 17
Development of SARS-CoV-2 entry antivirals
Meiyue Dong, Jazmin Galván Achi, Ruikun Du, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100144-100144
Open Access | Times Cited: 8
Meiyue Dong, Jazmin Galván Achi, Ruikun Du, et al.
Cell Insight (2024) Vol. 3, Iss. 1, pp. 100144-100144
Open Access | Times Cited: 8
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
T. Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 27
T. Kinoshita, Masahiro Shinoda, Yasuhiro Nishizaki, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 27
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105316-105316
Open Access | Times Cited: 27
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105316-105316
Open Access | Times Cited: 27
Isolation of ACE2-dependent and -independent sarbecoviruses from Chinese horseshoe bats
Hua Guo, Ang Li, Tian-Yi Dong, et al.
Journal of Virology (2023) Vol. 97, Iss. 9
Open Access | Times Cited: 15
Hua Guo, Ang Li, Tian-Yi Dong, et al.
Journal of Virology (2023) Vol. 97, Iss. 9
Open Access | Times Cited: 15
How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
Nabil G. Seidah, Antonella Pasquato, Ursula Andréo
Viruses (2021) Vol. 13, Iss. 7, pp. 1229-1229
Open Access | Times Cited: 30
Nabil G. Seidah, Antonella Pasquato, Ursula Andréo
Viruses (2021) Vol. 13, Iss. 7, pp. 1229-1229
Open Access | Times Cited: 30
Cell-Cell Fusion Mediated by Viruses and HERV-Derived Fusogens in Cancer Initiation and Progression
Thomas Dittmar, Julian Weiler, Tianjiao Luo, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5363-5363
Open Access | Times Cited: 29
Thomas Dittmar, Julian Weiler, Tianjiao Luo, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5363-5363
Open Access | Times Cited: 29
Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry
Zihui Zhu, Yutong Han, Mingli Gong, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 4
Zihui Zhu, Yutong Han, Mingli Gong, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 4
Coiled-coil heterodimers with increased stability for cellular regulation and sensing SARS-CoV-2 spike protein-mediated cell fusion
Tjaša Plaper, Jana Aupič, Petra Dekleva, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Tjaša Plaper, Jana Aupič, Petra Dekleva, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2
Raymond R. R. Rowland, Alberto Brandariz-Núñez
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 27
Raymond R. R. Rowland, Alberto Brandariz-Núñez
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 27